Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma. (LNH-RGDOX)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2009 by Centre de recherche du Centre hospitalier universitaire de Sherbrooke.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
ClinicalTrials.gov Identifier:
NCT01019863
First received: November 24, 2009
Last updated: January 11, 2011
Last verified: November 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2011
  Estimated Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)